HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease.

Abstract
Recent efforts have made significant progress in generating transgenic pigs with the DeltaF508-CFTR mutation to model the lung and pancreatic disease of human cystic fibrosis. However, species differences in the processing and function of human, pig and mouse DeltaF508-CFTR reported recently raise concerns about the phenotypic consequence of the gene-targeted pig model. The purpose of the present study was to characterize the DeltaF508 mutant of porcine CFTR to evaluate the severity of its processing defect. Biochemical and immunofluorescence analysis in transfected COS7 and FRT cells indicated that pig DeltaF508-CFTR efficiently targets to the plasma membrane and is present mainly as the mature glycosylated protein. Functional characterization in stably transfected FRT cells by fluorometric and electrophysiological assays supported efficient plasma membrane targeting of pig DeltaF508-CFTR. The mild cellular processing defect of pig DeltaF508-CFTR suggests that its gene-targeted pig model may not develop the lung and pancreatic phenotypes seen in CF patients.
AuthorsYanli Liu, Ying Wang, Yong Jiang, Na Zhu, Haitao Liang, Lina Xu, Xuechao Feng, Hong Yang, Tonghui Ma
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 373 Issue 1 Pg. 113-8 (Aug 15 2008) ISSN: 1090-2104 [Electronic] United States
PMID18555011 (Publication Type: Journal Article)
Chemical References
  • cystic fibrosis transmembrane conductance regulator delta F508
  • Cystic Fibrosis Transmembrane Conductance Regulator
Topics
  • Animals
  • Animals, Genetically Modified
  • COS Cells
  • Cell Membrane (metabolism)
  • Chlorocebus aethiops
  • Cloning, Molecular
  • Cystic Fibrosis (genetics, metabolism)
  • Cystic Fibrosis Transmembrane Conductance Regulator (genetics, metabolism)
  • Disease Models, Animal
  • Gene Targeting
  • Mutation
  • Rats
  • Species Specificity
  • Sus scrofa (genetics)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: